Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Henan Cancer Hospital"
Count: 140
Selected: 0
NCT IDTitle
NCT02621333Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
NCT04778800A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)
NCT02395705Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
NCT05023720Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
NCT04681287Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.
NCT04341857PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma
NCT04063683Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma(ESCC).
NCT03939962Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma
NCT04615312A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors
NCT05013697TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.
NCT04433156VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
NCT04263935Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
NCT04214626R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
NCT04660097Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
NCT04948125Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma
NCT04938297Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma
NCT03691051A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
NCT04901754Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer
NCT04891900TQB2450 (PD-L1 Inhibitor) Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma
NCT04891016Toripalimab Plus FLOT in Locally Advanced Gastric Cancer
NCT04553939Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer
NCT03881774Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
NCT03881761CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma
NCT04737889Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
NCT04718038Continuing Cetuximab Plus Chemotherapy After First Progression in Wild-type KRAS, NRAS and BRAF V600E Metastatic Colorectal Cancer
NCT04538833GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel
NCT04668365Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma
NCT04067037Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma
NCT04675866Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer
NCT04664972The TP Regimen in the Treatment of Early Triple Negative Breast Cancer
NCT04547907Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer, A Multicenter, Randomized, Phase III Clinical Trial
NCT04222790A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity
NCT03413436Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma
NCT03457337S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC
NCT03389087Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer
NCT02737774Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation
NCT04430361the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
NCT04268108L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy
NCT03983759Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer
NCT03950271SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma
NCT03478943The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province
NCT04280822Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
NCT03735966Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in Patients With HER2 Positive Breast Cancer
NCT03735511A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma
NCT04087252An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment
NCT03790228Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC
NCT03397199Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer
NCT04055792Sintilimab Combined With Anlotinib in Third Line or Beyond Among Advanced SCLC Patients
NCT04331626Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC
NCT03002831Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer